Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.
Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A. Gómez-López A, et al. Among authors: lopez sendon moreno jl. Brain Sci. 2021 Jan 6;11(1):57. doi: 10.3390/brainsci11010057. Brain Sci. 2021. PMID: 33418858 Free PMC article.
Dyskinesia-hyperpyrexia syndrome under continuous dopaminergic stimulation.
Acebrón Sánchez-Herrera F, García-Barragán N, Estévez-Fraga C, Martínez-Castrillo JC, López-Sendón Moreno JL. Acebrón Sánchez-Herrera F, et al. Parkinsonism Relat Disord. 2017 Mar;36:103-104. doi: 10.1016/j.parkreldis.2016.12.018. Epub 2016 Dec 29. Parkinsonism Relat Disord. 2017. PMID: 28049603 No abstract available.
Phenomenology and disease progression of chorea-acanthocytosis patients in Spain.
Estévez-Fraga C, López-Sendón Moreno JL, Martínez-Castrillo JC; Spanish Collaborative Neuroacanthocytosis Group. Estévez-Fraga C, et al. Parkinsonism Relat Disord. 2018 Apr;49:17-21. doi: 10.1016/j.parkreldis.2017.10.016. Epub 2017 Dec 20. Parkinsonism Relat Disord. 2018. PMID: 29317187 No abstract available.
Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience.
Martínez-Poles J, Nedkova-Hristova V, Escribano-Paredes JB, García-Madrona S, Natera-Villalba E, Estévez-Fraga C, López-Sendón Moreno JL, Avilés-Olmos I, Sánchez Díaz G, Martínez Castrillo JC, Alonso-Canovas A. Martínez-Poles J, et al. Toxins (Basel). 2018 May 28;10(6):217. doi: 10.3390/toxins10060217. Toxins (Basel). 2018. PMID: 29843420 Free PMC article.
Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
Alonso-Canovas A, Lopez-Sendon Moreno JL, Buisan J, Sainz de la Maza S, Costa-Frossard L, Garcia-Ribas G, de Felipe-Mimbrera A, Matute-Lozano MC, Zarza Sanz B, Toledano Delgado R, Corral I, Masjuan J, Martinez-Castrillo JC. Alonso-Canovas A, et al. J Neurol. 2018 Oct;265(10):2363-2369. doi: 10.1007/s00415-018-9006-5. Epub 2018 Aug 16. J Neurol. 2018. PMID: 30116942
Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism.
López-Sendón Moreno JL, Alonso-Cánovas A, Buisán Catevilla J, García Barragán N, Corral Corral I, de Felipe Mimbrera A, Matute Lozano MC, Masjuan Vallejo J, Martínez-Castrillo JC. López-Sendón Moreno JL, et al. Mov Disord Clin Pract. 2015 Dec 18;3(3):268-274. doi: 10.1002/mdc3.12281. eCollection 2016 May-Jun. Mov Disord Clin Pract. 2015. PMID: 30363526 Free PMC article.
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U. Alonso-Canovas A, et al. Parkinsonism Relat Disord. 2019 Nov;68:40-45. doi: 10.1016/j.parkreldis.2019.09.032. Epub 2019 Oct 1. Parkinsonism Relat Disord. 2019. PMID: 31621617
Eye-of-the-Tiger Sign with an Unexpected Pathological Diagnosis.
Natera-Villalba E, Martínez-Castrillo JC, López-Sendón Moreno JL, Gómez-López A, Sánchez-Sánchez A, López-Martínez MJ, Rábano A, Alonso-Cánovas A. Natera-Villalba E, et al. Among authors: lopez sendon moreno jl. Mov Disord Clin Pract. 2021 Nov 7;9(1):98-103. doi: 10.1002/mdc3.13366. eCollection 2022 Jan. Mov Disord Clin Pract. 2021. PMID: 35005073 Free PMC article.
[Biomarkers in Alzheimer's disease].
García-Ribas G, López-Sendón Moreno JL, García-Caldentey J. García-Ribas G, et al. Rev Neurol. 2014 Apr 1;58(7):308-17. Rev Neurol. 2014. PMID: 24677154 Free article. Review. Spanish.
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD; ACTIV-4a Investigators. Berger JS, et al. JAMA. 2022 Jan 18;327(3):227-236. doi: 10.1001/jama.2021.23605. JAMA. 2022. PMID: 35040887 Free PMC article. Clinical Trial.
29 results